Approval · Notice of Compliance 33117 · 2024
ZOMIG: Notice of Compliance 33117
Issued April 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33117
- Date
- April 25, 2024
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Expand the indication. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOMIG | Not yet assigned | — |
| ZOMIG NASAL SPRAY | Not yet assigned | — |
| ZOMIG RAPIMELT | Not yet assigned | — |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB
- ZOLMITRIPTAN 2.5 MG per ACT
- ZOLMITRIPTAN 5 MG per ACT